Carlos Romo, MD

Dr. Arthur Burnett is a professor of urology at the Johns Hopkins School of Medicine. He is the Patrick C. Walsh Professor of Urology. Dr. Burnett is the director of the Male Consultation Clinic at Johns Hopkins Hospital, a clinician-scientist at the James Buchanan Brady Urological Institute. Dr. Burnett is also Vice Chair for urology faculty development at the James Buchanan Brady Urological Institute Dr. Burnett received his undergraduate degree in biology from Princeton University and his medical degree at the Johns Hopkins University School of Medicine. He completed his internship and residency in surgery, and subsequently residency and fellowship in urology at The Johns Hopkins Hospital. Upon completion of his urology residency, he received an American Foundation of Urologic Disease New Investigator Award to continue research work into the regulatory mechanisms of penile erection. He has maintained an active laboratory in neurourology since that time. Dr. Burnett is an established expert in the areas of prostate cancer, lower genitourinary tract malignancies (penile, scrotal, and urethral cancers), lower genitourinary tract reconstruction (pelvic trauma and urethral stricture disease), erectile dysfunction and penile abnormalities (including Peyronies disease), and female urology (including urinary incontinence, urethral abnormalities, and prolapsed pelvic structures). He is an expert prostate cancer surgeon, having performed over 3,000 radical prostatectomies where he has proven his skill at applying a single, minimally invasive 3-inch incision just above the pubic bone to facilitate rapid recovery and cosmesis and using a nerve-sparing technique. He has also developed management approaches to improve postoperative functional outcomes following radical prostatectomy. Dr. Burnett is recognized for being a world-authority in the science and medicine of erectile dysfunction. He contributed original discoveries of the nitric oxide biochemical mechanisms in erectile tissue, which paved the way for the clinical development of oral medications to treat erectile dysfunction such as Viagra. He has also pioneered work to develop therapies to protect penile nerve function required for improved erectile function recovery after radical prostatectomy. Dr. Burnett has written more than 500 original peer-reviewed articles, along with numerous additional articles, editorials, and book chapters, and three books relating to his biomedical research and clinical activities. His work has appeared in many prominent journals such as Science, Nature Medicine, Proceedings of the National Academy of Sciences, New England Journal of Medicine, Journal of Urology, Urology, and Journal of Andrology. He has sat on various advisory committees including the Urology Study Section, National Institutes of Health Center for Scientific Review and FDA Advisory Committee for Reproductive Health Drugs. He also founded and directs a non-profit humanitarian organization called UroMissionsWorks Incorporated. He is an alumni member of the Alpha Omega Honor Medical Society and Fellow of the American College of Surgeons. Among various awards, Dr. Burnett received the Urology Care Foundation Distinguished Mentor Award in 2016, the Distinguished Contribution Award from the American Urological Association in 2018, the Ferdinand C. Valentine Medal from The New York Academy of Medicine in 2020, and the Hugh Hampton Young Award from the American Urological Association in 2022.

Liana Rosenthal, M.D. is an Assistant Professor in the Department of Neurology at Johns Hopkins University School of Medicine in Baltimore, Maryland. Dr. Rosenthal completed medical school at Johns Hopkins with an internship at Johns Hopkins Bayview Medical Center. She completed her neurology residency and movement disorder fellowship at The Johns Hopkins Hospital.

Dr. Kornberg completed his undergraduate studies at Yale University. He then received M.D. and Ph.D. degrees from the Johns Hopkins School of Medicine and stayed at Johns Hopkins for neurology residency and a clinical and research fellowship in neuroimmunology. He is committed to a career that combines the competent and compassionate care of patients with multiple sclerosis and other immunolgic disorders of the nervous system with basic and translational research aimed at developing improved therapies.